Ross J Porter

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Ulcerative Colitis

Top Venues

Frontline gastroenterology

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Ross J Porter, Shahida Din, Peter Bankhead, Anca Oniscu, Mark J Arends
QuPath Algorithm Accurately Identifies MLH1-Deficient Inflammatory Bowel Disease-Associated Colorectal Cancers in a Tissue Microarray. Diagnostics (Basel, Switzerland) 13 (11) (2023)
Ross J Porter, Graeme I Murray, Sandra Hapca, Andrew Hay, Stephanie G Craig, Matthew Phillip Humphries, Jacqueline A James, Manuel Salto-Tellez, Daniel P Brice, Susan H Berry, Mairi H McLean
Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an 'Immune Cold' Phenotype Associated with Poor Survival. Cancers 15 (6) (2023)
Ross J Porter, Graeme I Murray, Sandra Hapca, Andrew Hay, Stephanie G Craig, Matthew Phillip Humphries, Jacqueline A James, Manuel Salto-Tellez, Daniel P Brice, Susan H Berry, Mairi H McLean
Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an 'Immune Cold' Phenotype Associated with Poor Survival. Cancers 15 (6) (2023)
Daniel P Brice, Graeme I Murray, Heather M Wilson, Ross J Porter, Susan Berry, Scott K Durum, Mairi H McLean
Interleukin-27 Regulates the Function of the Gastrointestinal Epithelial Barrier in a Human Tissue-Derived Organoid Model. Biology 11 (3) (2022)
Ross J Porter, Alastair W McKinlay, Emma L Metcalfe
Endoscopically placed venting gastrostomy can be a safe and effective palliative intervention in benign and malignant gastrointestinal obstruction. Frontline gastroenterology 13 (4) (2021)
Ross J Porter, Rahul Kalla, Gwo-Tzer Ho
Ulcerative colitis: Recent advances in the understanding of disease pathogenesis. F1000Research 9 (2020)
Ross J Porter, Alastair W McKinlay, Emma L Metcalfe
Gastropexy can be as safe as conventional percutaneous endoscopic gastrostomy (PEG), and biomarkers do not predict short-term or long-term outcomes: a 7-year follow-up audit. Frontline gastroenterology 11 (5) (2019)